Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3

Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3

US Patent 7045129 · Granted May 16, 2006

Estimated economic value: $5,255,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for production of reprogrammed cell using chromosomally unintegrated viru2021
Method for improving efficiency of inducing pluripotent stem cell2021
Human CDR-grafted antibody and antibody fragment thereof2020
Method of modulating the activity of functional immune molecules2019
Antibody composition-producing cell2019
Human CDR-grafted antibody and antibody fragment thereof2018
Gene transfer into airway epithelial stem cell by using lentiviral vector pseudo2018
Method for production of reprogrammed cell using chromosomally unintegrated viru2017
Medicament comprising recombinant antibody against chemokine receptor CCR42017
Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived ce2016
Recombinant antibody composition2016
Method for producing induced pluripotent stem cells2016